Evaluating the efficacy of endoscopic sphincterotomy on biliary-type sphincter of Oddi dysfunction: A retrospective clinical trial

Table 1 General information of biliary-type sphincter of Oddi dysfunction patients

Characteristic	Type I, n = 29	Type IIa, n = 6	Type IIb, n = 44
Sex (male/female)	8/21	4/2	15/29
Age [mean (SD), yr]	59.10 ± 17.36	56.00 ± 19.03	58.84 ± 11.14
With FH (n)	1	0	4
With IBS (n)	0	0	2
With FD (n)	1	1	3
ALT [M (IQR), U/L]	209.90 (121.55-361.39)	170.02 (110.25-203.36)	25.65 (16.75-66.50)
AST [M (IQR), U/L]	194.66 (75.90-345.50)	136.78 (48.81-175.61)	28.00 (22.32-360.06)
TBIL [M (IQR), mg/dL]	4.52 (3.13-8.13)	6.09 (4.24-11.23)	1.69 (1.15-3.12)
ALP [M (IQR), U/L]	199.44 (155.73-311.78)	354.70 (201.68-470.88)	98.20 (78.20-117.40)
Bile duct diameter [M (IQR), cm]	1.20 (1.00-1.50)	0.80 (0.78-0.80)	1.50 (1.10-2.00)

FD: Functional dyspepsia; FH: Functional heartburn; IBS: Irritable bowel syndrome; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; TBIL: Total bilirubin; SD: SD; M; Median; IQR: Interquartile range.